why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: June 28, 2025

Clinical Trial: Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Breast Cancer

Study Type: OBSERVATIONAL


Official Title: A Multicenter Retrospective Analysis of the Miti-gene Recurrence Score in Early-Stage Invasive HR-Positive, HER2-Negative Breast Cancer in China

Brief Summary: Update and validate the performance of the 21-gene score in prognostic stratification for early-stage HR-positive, HER2-negative breast cancer in China.

Read more